Literature DB >> 9535646

Natural and engineered disorders of lymphocyte development.

A Fischer1, B Malissen.   

Abstract

Mammals have evolved complex developmental pathways to generate a large repertoire of B and T lymphocytes capable of mounting effective immune responses. Analysis of natural and engineered immunodeficiencies constitutes a powerful approach to delineating these pathways and identifying the molecular sensors that couple the survival of developing lymphocytes to the achievement of successful gene rearrangements at the loci coding for B and T cell antigen receptors. Besides identifying cytokines, growth factors, and transcription factors involved in lymphocyte development, genetic analysis also makes it possible to organize most of these protagonists into gene networks that control critical events in the life of developing lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535646     DOI: 10.1126/science.280.5361.237

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  Phenotypic identification of the subgroups of murine T-cell receptor alphabeta+ CD4+ CD8- thymocytes and its implication in the late stage of thymocyte development.

Authors:  Q Ge; W F Chen
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

2.  Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor.

Authors:  P Bousso; V Wahn; I Douagi; G Horneff; C Pannetier; F Le Deist; F Zepp; T Niehues; P Kourilsky; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  TCRalpha enhancer activation occurs via a conformational change of a pre-assembled nucleo-protein complex.

Authors:  S Spicuglia; D Payet; R K Tripathi; P Rameil; C Verthuy; J Imbert; P Ferrier; W M Hempel
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

5.  Promotion of cell cycle progression by basic helix-loop-helix E2A.

Authors:  F Zhao; A Vilardi; R J Neely; J K Choi
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  ShcA regulates late stages of T cell development and peripheral CD4+ T cell numbers.

Authors:  Monica W Buckley; Paul C Trampont; Sanja Arandjelovic; Aaron M Fond; Ignacio J Juncadella; Kodi S Ravichandran
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

7.  Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling.

Authors:  Guo Fu; Sébastien Vallée; Vasily Rybakin; Marielena V McGuire; Jeanette Ampudia; Claudia Brockmeyer; Mogjiborahman Salek; Paul R Fallen; John A H Hoerter; Anil Munshi; Yina H Huang; Jianfang Hu; Howard S Fox; Karsten Sauer; Oreste Acuto; Nicholas R J Gascoigne
Journal:  Nat Immunol       Date:  2009-07-13       Impact factor: 25.606

8.  Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.

Authors:  Rieka Go; Satoshi Hirose; Yoshinori Katsuragi; Miki Obata; Manabu Abe; Yukio Mishima; Kenji Sakimura; Ryo Kominami
Journal:  Cancer Sci       Date:  2013-06-17       Impact factor: 6.716

9.  The LMO2 T-cell oncogene is activated via chromosomal translocations or retroviral insertion during gene therapy but has no mandatory role in normal T-cell development.

Authors:  Matthew P McCormack; Alan Forster; Lesley Drynan; Richard Pannell; Terence H Rabbitts
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

10.  N-terminal RAG1 frameshift mutations in Omenn's syndrome: internal methionine usage leads to partial V(D)J recombination activity and reveals a fundamental role in vivo for the N-terminal domains.

Authors:  S Santagata; C A Gomez; C Sobacchi; F Bozzi; M Abinun; S Pasic; P Cortes; P Vezzoni; A Villa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.